Generate Biomedicines announced that its management team will present at the Guggenheim Healthcare Innovation Conference in Boston on November 9 and the Jefferies Global Healthcare Conference in London on November 16. These presentations will be webcast live and available for replay on the company's investor website. The company focuses on using AI and biological engineering to develop new drug candidates, aiming to transform drug discovery with its proprietary platform. Participation in these conferences highlights Generate's ongoing efforts to engage investors and showcase its innovative approach in the biotech sector.
Generate Biomedicines' upcoming investor conference participation is noted here with Pluang's Health-sector market data as of Oct 22, 2026 18:01 WIB: Of 150 priced Health-sector US stocks, 68 rose and 75 fell today. Notable movers include Medpace Holdings Inc (MEDP) at USD 642.01 with a -3.09% change and a typical hold time of 15 days, Zimmer Biomet Holdings Inc (ZBH) at USD 97.49 with a +2.77% change and a typical hold time of 89 days, and Ginkgo Bioworks Holdings Inc (DNA) at USD 9.75 with a -2.60% change and a typical hold time of 8 days. The highest typical hold time among these is 89 days for Zimmer Biomet Holdings Inc.
Drofa Comms has released the Women Leading the Way Digital Magazine 2026, aiming to highlight women experts in finance on equal terms with men. The digital magazine features insights from 25 industry professionals and covers topics like AI in wealth ...
Fortuna Mining Corp. will announce its financial results for the third quarter of 2026 on November 4, after market close. A conference call to discuss the results will be held on November 5 at 12 p.m. Eastern time, featuring the CEO and key executive...
Gogoro Inc., a leader in battery swapping technology for electric mobility, will announce its financial results for the third quarter ending September 30, 2026, on November 11 before the market opens. The company will hold a webcast at 7 a.m. Eastern...
Aclarion's Nociscan, a noninvasive scan for diagnosing painful lumbar discs, was validated in a new study by the London Spine Clinic showing up to 87% agreement with the invasive discography procedure. Nociscan offers a safer, less painful, and more ...
The PIMCO 0-5 Year High Yield Corporate Bond Index ETF provides a relatively high 7.6% distribution yield with a portfolio focused on non-investment-grade bonds. Its shorter duration helps reduce losses amid rising interest rates, and it benefits fro...
